Microbiome Interactions in Health and Disease
Wellcome Genome Campus, Hinxton, CB10 1RQ, UK
Web Address
https://coursesandconferences.wellcomeconnectingscience.org/event/microbiome-interactions-in-health-and-disease-2022102
Registration
Deadline: 27/09/2022
Click here to register
General Information
This conference will be a hybrid meeting – with onsite or virtual attendance.
6 Sept 2022 (abstract deadline)
27 Sept 2022 (in person registration deadline)
17 Oct 2022 (virtual registration deadline
Programme committee
Lindsay Hall – Technical University of Munich, Germany
Reetta Satokari – University of Helsinki, Finland
Alan Walker – University of Aberdeen, UK
Jerry Wells- Wageningen University & Research, The Netherlands
The 11th Microbiome Interactions in Health and Disease meeting will bring together leading scientists and clinicians from the fields of microbiology, gastroenterology, nutrition, cancer and public health to discuss the latest developments in this fast-moving area.
This year’s meeting will focus on cancer–microbiome interactions and the influence of the diet and nutrition on the microbiota that live in our digestive system. We will also discuss how viruses affecting respiratory health, including SARS-COV-2, can affect the microbiome, as well as the lessons learned on microbiome manipulation from the wider animal kingdom.
Topics will include:
• Microbiome and cancer
• Respiratory health, microbiome and the age of Covid
• Nutrition, metabolism and the microbiome
• Methological and modelling innovations
• Beyond bacteria
• Exploring the microbiome – lessons from the animal kingdom
Deadline for submissions: 6 Sept 2022 (abstract deadline)
Meeting organisers:
Wellcome Connecting Science
conferences@wellcomeconnectingscience.org
Speakers:
Keynote speakers
Ruth Ley – Max Planck Institute for Developmental Biology, Germany
Eran Segal – Weizmann Institute, Israel
Confirmed speakers
Amy Apprill – Woods Hole Oceanographic Institution, USA
Leah Cuthbertson – Imperial College London, UK
Sabina Leanti La Rosa – Norwegian University of Life Sciences, Norway
Spencer Diamond – University of California, Berkeley, USA
Sonia Fernandez-Veledo – University Hospital of Tarragona Joan XXIII – Pere Virgili Health Research Institute – CIBERDEM, Spain
Marnix Medema – Wageningen University, The Netherlands
Christine Moissl-Eichinger – Medical University of Graz, Austria
Imke Mulder – 4D Pharma, UK
Stephen Robinson – Quadram Institute Bioscience, UK
Andrey Shkoporov – APC Microbiome, Ireland
Erika von Mutius – Ludwig Maximilian University of Munich, Germany
